ARVADIX Trademark

Trademark Overview

On Monday, April 2, 2007, a trademark application was filed for ARVADIX with the United States Patent and Trademark Office. The USPTO has given the ARVADIX trademark a serial number of 79039290. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, April 3, 2017. This trademark is owned by BIOFARMA. The ARVADIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the cardio-vascular system
arvadix

General Information

Serial Number79039290
Word MarkARVADIX
Filing DateMonday, April 2, 2007
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, April 3, 2017
Registration Number3445513
Registration DateTuesday, June 10, 2008
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, March 25, 2008

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the cardio-vascular system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 16, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBIOFARMA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party NameBIOFARMA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party NameBIOFARMA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Friday, October 27, 2017NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, October 27, 2017DEATH OF INTERNATIONAL REGISTRATION
Friday, October 16, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, September 30, 2015TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, September 30, 2015INVALIDATION PROCESSED
Wednesday, September 16, 2015TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, January 16, 2015CANCELLED SECTION 71
Saturday, March 30, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, May 18, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, December 4, 2011CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, September 30, 2008FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, September 30, 2008FINAL DISPOSITION PROCESSED
Thursday, September 11, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 10, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, March 25, 2008PUBLISHED FOR OPPOSITION
Wednesday, March 5, 2008NOTICE OF PUBLICATION
Wednesday, February 20, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 20, 2008ASSIGNED TO LIE
Thursday, February 14, 2008ASSIGNED TO EXAMINER
Friday, January 18, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 11, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 11, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 11, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 11, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 10, 2007REFUSAL PROCESSED BY IB
Thursday, July 19, 2007NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, July 19, 2007REFUSAL PROCESSED BY MPU
Thursday, July 19, 2007NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, July 18, 2007NON-FINAL ACTION WRITTEN
Monday, July 16, 2007ASSIGNED TO EXAMINER
Monday, July 16, 2007NEW APPLICATION ENTERED IN TRAM
Friday, July 13, 2007LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Thursday, July 12, 2007SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

arvadix cardio vascular system disorders treatment preparations prevention pharmaceutical